Pneumonia Therapeutics Market: Innovations, Treatments, and Future Outlook
The global Pneumonia Therapeutics market is expected to reach USD 4.10 billion by 2030, at a CAGR of 8.9% during the forecast period 2022 to 2030. A significant contributing driver is the rise of pneumococcal illness. The prevalence of both community-acquired and ventilator-associated bacterial pneumonia has significantly increased over time.